本文選題：進展型腦梗死　切入點：尤瑞克林　出處：《中風與神經(jīng)疾病雜志》2017年04期 　論文類型：期刊論文

【摘要】：正急性進展型腦梗死是指腦梗死患者發(fā)病后神經(jīng)功能缺失癥狀在48 h內(nèi)逐漸進展或呈階梯式加重,治療目的主要是恢復缺血腦組織的供血供氧,促進神經(jīng)功能恢復,急性進展型腦梗死的治療有很多,包括溶栓、抗凝、抑制血小板聚集、清除氧自由基以及神經(jīng)保護等~([1]),雖然溶栓治療是治療急性缺血性卒中最有效的方法,但其嚴格的適應證和時間窗要
[Abstract]:Positive acute progressive cerebral infarction (ACI) refers to the progressive or stepwise exacerbation of neurological deficit in patients with cerebral infarction within 48 hours. The main purpose of treatment is to restore blood supply and oxygen supply to ischemic brain tissue and to promote the recovery of nerve function. There are many treatments for acute progressive cerebral infarction, including thrombolysis, anticoagulation, inhibition of platelet aggregation, scavenging of oxygen free radicals, and neuroprotection ([1]), although thrombolytic therapy is the most effective treatment for acute ischemic stroke. But its strict indication and time window must
【作者單位】： 吉化集團公司總醫(yī)院神經(jīng)內(nèi)科;
【分類號】：R743.33

【相似文獻】

相關(guān)期刊論文 前10條

1 茹海港;王見良;;進展型腦梗死血脂、血流變、血凝檢測的臨床意義[J];心腦血管病防治;2007年04期

2 戚英;趙衛(wèi)鋒;王s，

本文編號：1638812